• 9514 Citations
  • 31 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
Article

Age-period-cohort analysis of renal cell carcinoma in United States adults

Tyson, M. D., Humphreys, M. R., Parker, A. S., Thiel, D. D., Joseph, R. W., Andrews, P. E. & Castle, E. P., Jul 1 2013, In : Urology. 82, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

18 Scopus citations

A multidisciplinary biospecimen bank of renal cell carcinomas compatible with discovery platforms at Mayo Clinic, Scottsdale, Arizona

Ho, T. H., Nateras, R. N., Yan, H. D., Park, J. G., Jensen, S., Borges, C., Lee, J. H., Champion, M. D., Tibes, R., Bryce, A. H., Carballido, E. M., Todd, M. A., Joseph, R. W., Wong, W. W., Parker, A., Stanton, M. L. & Castle, E. P., Jul 16 2015, In : PLoS One. 10, 7, e0132831.

Research output: Contribution to journalArticle

6 Scopus citations

An integrated model of the transcriptome of HER2-positive breast cancer

Kalari, K. R., Necela, B. M., Tang, X., Thompson, K. J., Lau, M., Eckel-Passow, J. E., Kachergus, J. M., Keith Anderson, S., Sun, Z., Baheti, S., Carr, J. M., Baker, T. R., Barman, P., Radisky, D. C., Joseph, R. W., McLaughlin, S. A., Chai, H. S., Camille, S., Rossell, D., Asmann, Y. W. & 2 others, Aubrey Thompson, E. & Perez, E. A., Nov 1 2013, In : PloS one. 8, 11, e79298.

Research output: Contribution to journalArticle

11 Scopus citations

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma

Eckel-Passow, J. E., Serie, D. J., Bot, B. M., Joseph, R. W., Cheville, J. C. & Parker, A. S., Jan 31 2014, In : BMC Urology. 14, 1, 14.

Research output: Contribution to journalArticle

19 Scopus citations

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial

Robert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W. J., Gangadhar, T. C., Patnaik, A., Dronca, R., Zarour, H., Joseph, R. W., Boasberg, P., Chmielowski, B., Mateus, C., Postow, M. A., Gergich, K., Elassaiss-Schaap, J. & 5 others, Li, X. N., Iannone, R., Ebbinghaus, S. W., Kang, S. P. & Daud, A., Sep 20 2014, In : The Lancet. 384, 9948, p. 1109-1117 9 p.

Research output: Contribution to journalArticle

1121 Scopus citations

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

Kim, K. B., Prieto, V., Joseph, R. W., Diwan, A. H., Gallick, G. E., Papadopoulos, N. E., Bedikian, A. Y., Camacho, L. H., Hwu, P., Ng, C. S., Wei, W., Johnson, M. M., Wittemer, S. M., Vardeleon, A., Reckeweg, A. & Colevas, A. D., Aug 1 2012, In : Melanoma research. 22, 4, p. 294-301 8 p.

Research output: Contribution to journalArticle

36 Scopus citations

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis

Eckel-Passow, J. E., Igel, D. A., Serie, D. J., Joseph, R. W., Ho, T. H., Cheville, J. C. & Parker, A., Feb 1 2015, In : Urologic Oncology. 33, 2

Research output: Contribution to journalArticle

5 Scopus citations
2 Scopus citations

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

DeLeon, T. T., Almquist, D. R., Kipp, B. R., Langlais, B. T., Mangold, A., Winters, J. L., Kosiorek, H. E., Joseph, R. W., Dronca, R. S., Block, M. S., McWilliams, R. R., Kottschade, L. A., Rumilla, K. M., Voss, J. S., Seetharam, M., Sekulic, A., Markovic, S. N. & Bryce, A. H., Jan 1 2020, In : PloS one. 15, 3, e0230306.

Research output: Contribution to journalArticle

Open Access

Association between programmed death-Ligand 1 expression and the vascular endothelial growth factor pathway in angiosarcoma

Bagaria, S. P., Gatalica, Z., Maney, T., Serie, D., Parasramka, M., Attia, S., Krishna, M. & Joseph, R. W., Mar 22 2018, In : Frontiers in Oncology. 8, MAR, 71.

Research output: Contribution to journalArticle

5 Scopus citations

Association of pembrolizumab with tumor response and survival among patients with advanced melanoma

Ribas, A., Hamid, O., Daud, A., Hodi, F. S., Wolchok, J. D., Kefford, R., Joshua, A. M., Patnaik, A., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Hersey, P., Dronca, R. S., Joseph, R. W., Zarour, H., Chmielowski, B., Lawrence, D. P., Algazi, A., Rizvi, N. A., Hoffner, B. & 8 others, Mateus, C., Gergich, K., Lindia, J. A., Giannotti, M., Li, X. N., Ebbinghaus, S., Kang, S. P. & Robert, C., Apr 19 2016, In : JAMA - Journal of the American Medical Association. 315, 15, p. 1600-1609 10 p.

Research output: Contribution to journalArticle

467 Scopus citations

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer

Ho, T. H., Nunez-Nateras, R., Hou, Y. X., Bryce, A. H., Northfelt, D. W., Dueck, A., Wong, B., Stanton, M. L., Joseph, R. W. & Castle, E. P., Jul 8 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

3 Scopus citations

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., Dawson, N. A., van der Heijden, M. S., Dreicer, R., Srinivas, S., Retz, M. M., Joseph, R. W., Drakaki, A., Vaishampayan, U. N., Sridhar, S. S., Quinn, D. I. & 15 others, Durán, I., Shaffer, D. R., Eigl, B. J., Grivas, P. D., Yu, E. Y., Li, S., Kadel, E. E., Boyd, Z., Bourgon, R., Hegde, P. S., Mariathasan, S., Thåström, A. C., Abidoye, O. O., Fine, G. D. & Bajorin, D. F., Jan 7 2017, In : The Lancet. 389, 10064, p. 67-76 10 p.

Research output: Contribution to journalArticle

650 Scopus citations

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

Rosenberg, J. E., Hoffman-Censits, J., Powles, T., Van Der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., Srinivas, S., Retz, M. M., Grivas, P., Joseph, R. W., Galsky, M. D., Fleming, M. T., Petrylak, D. P., Perez-Gracia, J. L., Burris, H. A., Castellano, D. & 11 others, Canil, C., Bellmunt, J., Bajorin, D., Nickles, D., Bourgon, R., Frampton, G. M., Cui, N., Mariathasan, S., Abidoye, O., Fine, G. D. & Dreicer, R., May 7 2016, In : The Lancet. 387, 10031, p. 1909-1920 12 p.

Research output: Contribution to journalArticle

1555 Scopus citations

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: Post-progression outcomes from the phase II IMvigor210 study

Necchi, A., Joseph, R. W., Loriot, Y., Hoffman-Censits, J., Perez-Gracia, J. L., Petrylak, D. P., Derleth, C. L., Tayama, D., Zhu, Q., Ding, B., Kaiser, C. & Rosenberg, J. E., Dec 1 2017, In : Annals of Oncology. 28, 12, p. 3044-3050 7 p.

Research output: Contribution to journalArticle

42 Scopus citations

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor

Eckel-Passow, J. E., Serie, D. J., Cheville, J. C., Ho, T. H., Kapur, P., Brugarolas, J., Thompson, R. H., Leibovich, B. C., Kwon, E. D., Joseph, R. W. & Parker, A. S., Mar 21 2017, In : BMC Urology. 17, 1, p. 1-7 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab

Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W. J., Wolchok, J. D., Joshua, A. M., Ribas, A., Hodi, F. S., Hamid, O., Robert, C., Daud, A., Dronca, R., Hersey, P., Weber, J. S., Patnaik, A., De Alwis, D. P., Perrone, A., Zhang, J., Kang, S. P., Ebbinghaus, S. & 2 others, Anderson, K. M. & Gangadhar, T. C., Oct 15 2018, In : Clinical Cancer Research. 24, 20, p. 4960-4967 8 p.

Research output: Contribution to journalArticle

57 Scopus citations

Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2

Joseph, R. W., Eckel-Passow, J. E., Sharma, R., Liu, P., Parker, A., Jakob, J., Buchbinder, E., Bassett, R. L., Davies, M. A., Hwu, P., Atkins, M. B. & Sullivan, R. J., Nov 1 2012, In : Journal of Immunotherapy. 35, 9, p. 711-715 5 p.

Research output: Contribution to journalArticle

16 Scopus citations

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression

Joseph, R. W., Kapur, P., Serie, D. J., Parasramka, M., Ho, T. H., Cheville, J. C., Frenkel, E., Parker, A. & Brugarolas, J., Jan 1 2016, In : Journal of Urology. 195, 1, p. 180-187 8 p.

Research output: Contribution to journalArticle

62 Scopus citations

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness

Serie, D. J., Joseph, R. W., Cheville, J. C., Ho, T. H., Parasramka, M., Hilton, T., Thompson, R. H., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2016, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

17 Scopus citations

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., Sznol, M., Hainsworth, J., Rathmell, W. K., Stadler, W. M., Hutson, T., Gore, M. E., Ravaud, A., Bracarda, S., Suárez, C., Danielli, R. & 12 others, Gruenwald, V., Choueiri, T. K., Nickles, D., Jhunjhunwala, S., Piault-Louis, E., Thobhani, A., Qiu, J., Chen, D. S., Hegde, P. S., Schiff, C., Fine, G. D. & Powles, T., Jun 1 2018, In : Nature Medicine. 24, 6, p. 749-757 9 p.

Research output: Contribution to journalArticle

197 Scopus citations

Clinical features of acquired resistance to anti-PD-1 therapy in advanced melanoma

Wang, D. Y., Eroglu, Z., Ozgun, A., Leger, P. D., Zhao, S., Ye, F., Luke, J. J., Joseph, R. W., Haq, R., Ott, P. A., Hodi, F. S., Sosman, J. A., Johnson, D. B. & Buchbinder, E. I., May 1 2017, In : Cancer immunology research. 5, 5, p. 357-362 6 p.

Research output: Contribution to journalArticle

10 Scopus citations

C-MET expression in primary and liver metastases in uveal melanoma

Gardner, F. P., Serie, D. J., Salomao, D. R., Wu, K. J., Markovic, S. N., Pulido, J. S. & Joseph, R. W., Dec 10 2014, In : Melanoma research. 24, 6, p. 617-620 4 p.

Research output: Contribution to journalArticle

17 Scopus citations

Comprehensive genomic profiling of a rare thyroid follicular dendritic cell sarcoma

Davila, J. I., Starr, J. S., Attia, S., Wang, C., Knudson, R. A., Necela, B. M., Sarangi, V., Sun, Z. D., Ren, Y., Casler, J. D., Menke, D. M., Oliver, G. R., Joseph, R. W., Copland, J. A. III., Parker, A., Kocher, J-P., Thompson, E. A., Smallridge, R. C. & Asmann, Y., Sep 15 2017, In : Rare Tumors. 9, 2, p. 50-53 4 p., 6834.

Research output: Contribution to journalArticle

1 Scopus citations

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response

Ho, T. H., Choueiri, T. K., Wang, K., Karam, J. A., Chalmers, Z., Frampton, G., Elvin, J. A., Johnson, A., Liu, X., Lin, Y., Joseph, R. W., Stanton, M. L., Miller, V. A., Stephens, P. J., Ross, J. S., Ali, S. M. & Pal, S. K., Jun 1 2016, In : European Urology Focus. 2, 2, p. 204-209 6 p.

Research output: Contribution to journalArticle

19 Scopus citations

Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy

Swaika, A., Hammond, W. A. & Joseph, R. W., Oct 1 2015, In : Molecular Immunology. 67, 2, p. 4-17 14 p.

Research output: Contribution to journalArticle

127 Scopus citations

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis

Zhu, P., Stanton, M. L., Castle, E. P., Joseph, R. W., Adams, D. L., Li, S., Amstutz, P., Tang, C. M. & Ho, T. H., Jul 2 2016, In : Journal of Translational Medicine. 14, 1, 198.

Research output: Contribution to journalArticle

8 Scopus citations

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes

Ho, T. H., Serie, D. J., Parasramka, M., Cheville, J. C., Bot, B. M., Tan, W., Wang, L. M., Joseph, R. W., Hilton, T., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2017, In : Annals of Oncology. 28, 3, p. 604-610 7 p.

Research output: Contribution to journalArticle

25 Scopus citations

Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma

Robert, C., Ribas, A., Hamid, O., Daud, A., Wolchok, J. D., Joshua, A. M., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Joseph, R. W., Dronca, R., Patnaik, A., Zarour, H., Kefford, R., Hersey, P., Zhang, J., Anderson, J., Diede, S. J., Ebbinghaus, S. & Hodi, F. S., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1668-1674 7 p.

Research output: Contribution to journalArticle

115 Scopus citations

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program

Gangadhar, T. C., Hwu, W. J., Postow, M. A., Hamid, O., Daud, A., Dronca, R. S., Joseph, R. W., O'Day, S. J., Hodi, F. S., Pavlick, A. C., Kluger, H., Oxborough, R. P., Yang, A., Gazdoiu, M., Kush, D. A., Ebbinghaus, S. & Salama, A. K. S., 2017, In : Journal of Immunotherapy. 40, 9, p. 334-340 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Erratum to: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (Nature Medicine, (2018), 24, 6, (749-757), 10.1038/s41591-018-0053-3)

McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., Sznol, M., Hainsworth, J., Rathmell, W. K., Stadler, W. M., Hutson, T., Gore, M. E., Ravaud, A., Bracarda, S., Suárez, C., Danielli, R. & 12 others, Gruenwald, V., Choueiri, T. K., Nickles, D., Jhunjhunwala, S., Piault-Louis, E., Thobhani, A., Qiu, J., Chen, D. S., Hegde, P. S., Schiff, C., Fine, G. D. & Powles, T., Jan 1 2018, (Accepted/In press) In : Nature Medicine.

Research output: Contribution to journalArticle

1 Scopus citations

Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab

Hodi, F. S., Hwu, W. J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., Joshua, A. M., Hersey, P., Dronca, R. S., Joseph, R. W., Hille, D., Xue, D., Li, X. N., Kang, S. P., Ebbinghaus, S., Perrone, A. & 1 others, Wolchok, J. D., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

361 Scopus citations

Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer

Tavlarides, A. M., Ames, S. C., Diehl, N. N., Joseph, R. W., Castle, E. P., Thiel, D. D., Broderick, G. A. & Parker, A. S., Jun 1 2013, In : Psycho-Oncology. 22, 6, p. 1328-1335 8 p.

Research output: Contribution to journalArticle

23 Scopus citations

Factors associated with immunotherapy selection in patients with advanced melanoma

Joseph, R. W., Shillington, A. C., Macahilig, C., Diede, S. J., Dave, V., Harshaw, Q. & Liu, F. X., Nov 1 2018, In : Immunotherapy. 10, 16, p. 1361-1369 9 p.

Research output: Contribution to journalArticle

2 Scopus citations

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R., Weber, J. S., Dronca, R., Mitchell, T. C., Patnaik, A., Zarour, H. M., Joshua, A. M., Zhao, Q., Jensen, E., Ahsan, S., Ibrahim, N. & Ribas, A., Jan 1 2019, In : Annals of Oncology. 30, 4, p. 582-588 7 p., mdz011.

Research output: Contribution to journalArticle

Open Access
66 Scopus citations

Follicular dendritic cell sarcoma presenting as a thyroid mass

Starr, J. S., Attia, S., Joseph, R. W., Menke, D., Casler, J. & Smallridge, R. C., Jun 10 2015, In : Journal of Clinical Oncology. 33, 17, p. e74-e76

Research output: Contribution to journalArticle

9 Scopus citations

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma

Parker, A. S., Eckel-Passow, J. E., Serie, D., Hilton, T., Parasramka, M., Joseph, R. W., Wu, K. J., Cheville, J. C. & Leibovich, B. C., Nov 1 2014, In : European urology. 66, 5, p. 929-935 7 p.

Research output: Contribution to journalArticle

19 Scopus citations

High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation

Joseph, R. W., Alousi, A., Konda, B., Komanduri, K., Neumann, J., Trevino, C., Stolar, K., Qazilbash, M., Hosing, C., Kebriaei, P., Couriel, D. R., Champlin, R. E., Saliba, R. & Popat, U., Nov 1 2011, In : American journal of hematology. 86, 11, p. 954-956 3 p.

Research output: Contribution to journalArticle

17 Scopus citations

High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma

Ho, T. H., Park, I. Y., Zhao, H., Tong, P., Champion, M. D., Yan, H. D., Monzon, F. A., Hoang, A., Tamboli, P., Parker, A., Joseph, R. W., Qiao, W., Dykema, K., Tannir, N. M., Castle, E. P., Nunez-Nateras, R., Teh, B. T., Wang, J., Walker, C. L., Hung, M. C. & 1 others, Jonasch, E., Jun 15 2015, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

33 Scopus citations

High response rate to PD-1 blockade in desmoplastic melanomas

Eroglu, Z., Zaretsky, J. M., Hu-Lieskovan, S., Kim, D. W., Algazi, A., Johnson, D. B., Liniker, E., Kong, B., Munhoz, R., Rapisuwon, S., Gherardini, P. F., Chmielowski, B., Wang, X., Shintaku, I. P., Wei, C., Sosman, J. A., Joseph, R. W., Postow, M. A., Carlino, M. S., Hwu, W. J. & 5 others, Scolyer, R. A., Messina, J., Cochran, A. J., Long, G. V. & Ribas, A., Jan 18 2018, In : Nature. 553, 7688, p. 347-350 4 p.

Research output: Contribution to journalArticle

84 Scopus citations

Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers

Joseph, R. W., Shillington, A. C., Lee, T. A., Macahilig, C. P., Diede, S. J., Dave, V., Harshaw, Q., Scherrer, E. & Liu, F. X., Feb 1 2020, In : Journal of Medical Economics. 23, 2, p. 132-138 7 p.

Research output: Contribution to journalArticle

Open Access

Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy

Duma, N., Azzouqa, A. G., Yadav, S., Hoversten, K., Reed, C., Sitek, A. N., Lou, Y., Molina, J., Halfdanarson, T., Leventakos, K., Joseph, R. W., Manochakian, R. & Dronca, R., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii432

Research output: Contribution to journalArticle

Open Access

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy

Joseph, R. W., Peddareddigari, V. R., Liu, P., Miller, P. W., Overwijk, W. W., Bekele, N. B., Ross, M. I., Lee, J. E., Gershenwald, J. E., Lucci, A., Prieto, V. G., McMannis, J. D., Papadopoulos, N., Kim, K., Homsi, J., Bedikian, A., Hwu, W. J., Hwu, P. & Radvanyi, L. G., Jul 15 2011, In : Clinical Cancer Research. 17, 14, p. 4882-4891 10 p.

Research output: Contribution to journalArticle

34 Scopus citations

Inositol hexaphosphate plus inositol induced complete remission in stage IV melanoma: a case report

Khurana, S., Baldeo, C. & Joseph, R. W., Jun 1 2019, In : Melanoma research. 29, 3, p. 322-324 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma

Joseph, R. W., Parasramka, M., Eckel-Passow, J. E., Serie, D., Wu, K., Jiang, L., Kalari, K., Thompson, R. H., Huu Ho, T., Castle, E. P., Cheville, J., Kwon, E. D., Thompson, E. A. & Parker, A., Dec 1 2013, In : Cancer Immunology Research. 1, 6, p. 378-385 8 p.

Research output: Contribution to journalArticle

22 Scopus citations

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Zimmer, L., Apuri, S., Eroglu, Z., Kottschade, L. A., Forschner, A., Gutzmer, R., Schlaak, M., Heinzerling, L., Krackhardt, A. M., Loquai, C., Markovic, S. N., Joseph, R. W., Markey, K., Utikal, J. S., Weishaupt, C., Goldinger, S. M., Sondak, V. K., Zager, J. S., Schadendorf, D. & Khushalani, N. I., Apr 1 2017, In : European Journal of Cancer. 75, p. 47-55 9 p.

Research output: Contribution to journalArticle

58 Scopus citations

Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy

Joseph, R. W., Cappel, M., Goedjen, B., Gordon, M., Kirsch, B., Gilstrap, C., Bagaria, S. & Jambusaria-Pahlajani, A., Jan 1 2015, In : Cancer immunology research. 3, 1, p. 18-22 5 p.

Research output: Contribution to journalArticle

62 Scopus citations

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

Joseph, R. W., Kapur, P., Serie, D. J., Eckel-Passow, J. E., Parasramka, M., Ho, T., Cheville, J. C., Frenkel, E., Rakheja, D., Brugarolas, J. & Parker, A., Jan 1 2014, In : Cancer. 120, 7, p. 1059-1067 9 p.

Research output: Contribution to journalArticle

75 Scopus citations

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

Ho, T. H., Kapur, P., Joseph, R. W., Serie, D. J., Eckel-Passow, J. E., Tong, P., Wang, J., Castle, E. P., Stanton, M. L., Cheville, J. C., Jonasch, E., Brugarolas, J. & Parker, A., Jan 1 2016, In : Modern Pathology. 29, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Ho, T. H., Kapur, P., Joseph, R. W., Serie, D. J., Eckel-Passow, J. E., Parasramka, M., Cheville, J. C., Wu, K. J., Frenkel, E., Rakheja, D., Stefanius, K., Brugarolas, J. & Parker, A. S., Jan 1 2015, In : Urologic Oncology: Seminars and Original Investigations. 33, 1, p. 23.e9-23.e14

Research output: Contribution to journalArticle

25 Scopus citations